Following the international expansion in South Korea, Vietnam and Indonesia, HautAI skin aging tech now enters the Chinese market.
Estonia-based Haut.AI OU announced today that it has become a resident of Johnson & Johnson Innovation – JLABS @ Shanghai. Haut.AI OU is working towards increasing its number of skin aging R&D collaborations to support its mission of developing fully autonomous recommendation systems and AI-driven research tools to maximise the health and longevity of human skin.
Longevity.Technology: The modern skincare and personal care field is science-driven and based on continual innovation and product development through R&D. To keep pace with the ever-expanding expectations and consumer preferences, we are seeing a shift towards products and services that are hyper-personalised, inclusive and claims-supported. Of course, this puts pressure on companies’ R&D teams to create new products and formulations tailored to a range of different skin and hair types and to consider how formulations need to change with the age of the user. Add tackling aging into the mix, and things get complicated fast.
On top of this, the pandemic has put additional weight on the already complex and multifaceted process of conducting consumer studies and product testing. All of these factors have contributed significantly to the growing demand for innovative tools that help R&D teams with their cosmetic claims collection processes.
Established in 2018, Haut.AI initially emerged as a skin aging research organisation focused on image-based methods for skin evaluation. Haut.AI has supported the R&D activities of major skincare players and enabled the collection of thousands of data points in remote consumer and in vivo product evaluations.
Haut.AI currently provides a wide range of innovative AI-based software solutions for cosmetic and dermatocosmetic R&D, consumer-facing applications and patient support programs. HautAI uses a proprietary, inclusive AI and computer vision technology for the analysis of skin, hair and nails with more than 100 image-based visual biomarkers. This technology was developed in collaboration with data scientists, skin scientists and industry leaders in dermatology. It has been validated on a diverse dataset of more than three million images to ensure it performs equally well on a wide spectrum of people.
Haut.AI’s digital innovation platform allows beauty and wellness brands to conduct various types of consumer studies remotely, without any significant loss of efficiency or accuracy. Haut.AI’s solution for remote standardised data collection has been shown to increase the number of high-quality pictures and survey data collected during remote studies from 32% to 81%. The platform is also secured with end-to-end encryption.
Haut.AI has recently declared its strategic goals for 2022. Of particular note, the company aims to expand its presence in the Asian market; the Asian skincare market is currently valued at over $62 billion, with facial skincare accounting for 74% of total revenue, according to market research carried out by Statista in November 2021. This market is expected to grow annually by 7.42% and reach $89 billion by 2026. To date, Haut.AI has provided its services in South Korea, Vietnam and Indonesia, and it has recently entered the Chinese market.
Four of the five top countries in the sale of skincare products are based in Asia (Japan, China, South Korea and India). And while the US is the global skincare market leader right now, Japan is not far behind – and is expected to outperform it in 2024.
To successfully compete on the global market, Asian cosmetics companies must gain an advantage by staying ahead of emerging trends. This is achieved by creating new hyper-personalised and highly effective products, and by innovating to take advantage of the latest breakthroughs in understanding skin aging, whether that’s targeting mitchondrial dysfunction, reprograming with Yamanaka factors or addressing senescence.